The Potential Utility of HPV Genotyping in Screening and Clinical Management

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.6, Iss.1, 2008-01, pp. : 83-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Utility of Thiopurine S -Methyltransferase Genotyping

By Corominas H.

American Journal of PharmacoGenomics, Vol. 4, Iss. 1, 2004-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of irinotecan: clinical perspectives on the utility of genotyping

By Innocenti Federico Ratain Mark J

Pharmacogenomics, Vol. 7, Iss. 8, 2006-12 ,pp. : 1211-1221

Future Medicine

Access to resources Recommend Favorite

Valaciclovir:development, clinical utility and potential

By Patel R.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 2, 1997-02 ,pp. : 173-189

Informa Healthcare

Access to resources Recommend Favorite

AMPA receptor agonists, antagonists and modulators: their potential for clinical utility

By Bigge C.F. Nikam S.S.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 10, 1997-10 ,pp. : 1099-1114

Informa Healthcare

Access to resources Recommend Favorite

Editorial (Hot Topic: Exploring Molecular and Clinical Management of Patients in the Follow Up of the HPV Related Uterine Lesions)

Current Pharmaceutical Design, Vol. 19, Iss. 8, 2013-03 ,pp. : 1357-1357

Bentham Science Publishers

Access to resources Recommend Favorite